• SENSEX
    NIFTY 50
Business

Lupin Q4 key takeaways: Margins under pressure even as sales better than expected

Updated : May 29, 2020 05:53 PM IST

Credit Suisse in its note pointed out that cost control ‘was not visible yet’ with both personnel and other expenses higher than expected
A more near term trigger is concern over the presence of cancer-causing substance NDMA in diabetes drug Metformin
Lupin Q4 key takeaways: Margins under pressure even as sales better than expected

You May Also Like

Live TV
Advertisement